We subsequently produced a far more unique probe, [18F]CFA, which was used in The existing review To judge dCK activity in tumors when addressed with a small molecule dCK inhibitor. This probe is also remaining examined in a medical demo at our establishment To judge modifications in dCK activity subsequent cancer immunotherapy 18. PET probes in pr